![]() PIM447 structure
|
Common Name | PIM447 | ||
---|---|---|---|---|
CAS Number | 1210608-43-7 | Molecular Weight | 440.461 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 493.7±45.0 °C at 760 mmHg | |
Molecular Formula | C24H23F3N4O | Melting Point | N/A | |
MSDS | N/A | Flash Point | 252.4±28.7 °C |
Use of PIM447PIM447 is novel pan-PIM kinase inhibitor, including Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase.target: pan-PIM inhibitor [2] [3]In vitro: PIM447 is cytotoxic for myeloma cells due to cell cycle disruption and induction of apoptosis mediated by a decrease in phospho-Bad (Ser112) and c-Myc levels and the inhibition of mTORC1 pathway. PIM447 also inhibits in vitro osteoclast formation and resorption, downregulates key molecules involved in these processes and partially disrupts the F-actin ring, while increasing osteoblast activity and mineralization.[1]In vivo: PIM447 significantly reduces the tumor burden and preventes tumor-associated bone loss in a disseminated murine model of human myeloma.[1] |
Name | PIM447 |
---|---|
Synonym | More Synonyms |
Description | PIM447 is novel pan-PIM kinase inhibitor, including Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase.target: pan-PIM inhibitor [2] [3]In vitro: PIM447 is cytotoxic for myeloma cells due to cell cycle disruption and induction of apoptosis mediated by a decrease in phospho-Bad (Ser112) and c-Myc levels and the inhibition of mTORC1 pathway. PIM447 also inhibits in vitro osteoclast formation and resorption, downregulates key molecules involved in these processes and partially disrupts the F-actin ring, while increasing osteoblast activity and mineralization.[1]In vivo: PIM447 significantly reduces the tumor burden and preventes tumor-associated bone loss in a disseminated murine model of human myeloma.[1] |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 493.7±45.0 °C at 760 mmHg |
Molecular Formula | C24H23F3N4O |
Molecular Weight | 440.461 |
Flash Point | 252.4±28.7 °C |
Exact Mass | 440.182404 |
LogP | 5.20 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Index of Refraction | 1.593 |
Storage condition | -20℃ |
9TG5O4V25H |
N-{4-[(1R,3S,5S)-3-Amino-5-methylcyclohexyl]-3-pyridinyl}-6-(2,6-difluorophenyl)-5-fluoro-2-pyridinecarboxamide |
2-Pyridinecarboxamide, N-[4-[(1R,3S,5S)-3-amino-5-methylcyclohexyl]-3-pyridinyl]-6-(2,6-difluorophenyl)-5-fluoro- |
N-{4-[(1r,3s,5s)-3-Amino-5-Methylcyclohexyl]pyridin-3-Yl}-6-(2,6-Difluorophenyl)-5-Fluoropyridine-2-Carboxamide |